Shire News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.10.18	Seven & i Holdings Co., Ltd. -- Moody's: Rated Japanese corporates' cash to stay high, but pace of growth to slow (Moodys)
10.10.18	Seven & i Holdings Co., Ltd. -- Moody's: Rated Japanese corporates' cash to stay high, but pace of growth to slow (Japanese) (Moodys)
21.09.18	Shire Receives Approval of FIRAZYR® (icatibant injection) for the Treatment of Hereditary Angioedema (HAE) Attacks in Japan (GlobeNewswire)
20.09.18	Health Canada has authorized TAKHZYRO(TM) (lanadelumab injection), a first-of-its-kind monoclonal antibody treatment for the prevention of hereditary angioedema (HAE) attacks (GlobeNewswire)
14.09.18	Takeda gets China's approval for $62 billion Shire purchase (Reuters)
12.09.18	Shire Granted EU Marketing Authorization for Veyvondi® for Adults With Von Willebrand Disease (GlobeNewswire)
10.09.18	SHIRE ANNOUNCES THE PRICING TERMS AND INCREASE IN THE MAXIMUM TENDER AMOUNT OF THE PREVIOUSLY ANNOUNCED CASH TENDER OFFERS FOR CERTAIN OUTSTANDING NOTES (GlobeNewswire)
10.09.18	SHIRE ANNOUNCES EARLY RESULTS OF THE PREVIOUSLY ANNOUNCED CASH TENDER OFFERS FOR CERTAIN OUTSTANDING NOTES (GlobeNewswire)
06.09.18	Shire Acquires sanaplasma AG Boosting Plasma Collection Network for Immunology Franchise (GlobeNewswire)
31.08.18	Shire Completes Sale of Oncology Franchise (GlobeNewswire)
24.08.18	SHIRE ANNOUNCES CASH TENDER OFFERS FOR UP TO $2,250,000,000 OUTSTANDING PRINCIPAL AMOUNT OF NOTES (GlobeNewswire)
24.08.18	Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema (GlobeNewswire)
13.08.18	New Drug Application Submitted in Japan for INTUNIV® (guanfacine hydrochloride extended release) in Adults with ADHD (GlobeNewswire)
22.06.18	Shire plc: Large-Scale European Review Suggests Disparity in Symptom Recognition and Standardized Treatment for Metastatic Adenocarcinoma of the Pancreas (GlobeNewswire)
21.06.18	Shire Receives U.S. FDA Approval for New State-of-the-Art Plasma Manufacturing Facility Near Covington, Georgia (GlobeNewswire)
21.06.18	Shire Announces FDA Approval for Label Expansion of CINRYZE® for Prevention of Attacks in Pediatric HAE (GlobeNewswire)
22.05.18	Shire announces new hypoparathyroidism data at the 2018 European Congress of Endocrinology (GlobeNewswire)
09.05.18	Shire Acq Inv Ireland Designated Activity Co -- Moody's reviews Shire's Baa3 ratings for upgrade (Moodys)
09.05.18	Takeda Pharmaceutical Company Limited -- Moody's downgrades Takeda Pharmaceutical to A2; places ratings on review for further downgrade (Moodys)
25.04.18	Shire Acq Inv Ireland Designated Activity Co -- Moody's: An acquisition of Shire by Takeda could have positive or negative implications for Shire (Moodys)
25.04.18	Analysis: Shire bid marks Takeda's latest - and biggest - push for global status (Reuters)
25.04.18	Takeda kommt Shire-Übernahme näher - Iren signalisieren Zustimmung (AWP) Der japanische Pharmakonzern Takeda könnte beim wiederholten Anlauf um die Übernahme des irischen Rivalen Shire womöglich bald den grossen Durchbruch erzielen.» mehr
25.04.18	Takeda Pharmaceutical Company Limited -- Moody's: Takeda's latest offer to acquire Shire would further increase debt (Moodys)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	51.86	1.25 %	K V
Swiss Life Hldg	773.00	1.18 %	K V
Lonza Grp	601.80	1.07 %	K V
UBS Group	30.43	0.83 %	K V
Zurich Insur Gr	567.80	0.78 %	K V
Logitech Intl	94.18	-0.19 %	K V
Givaudan	4’042.00	-0.42 %	K V
Sika	240.20	-0.78 %	K V
Swisscom	495.80	-0.80 %	K V
Sonova Hldg	299.00	-1.19 %	K V

mehr

17:58		Aufschläge in Europa: Zum Handelsende Gewinne im STOXX 50
17:58		Freundlicher Handel in London: FTSE 100 zum Handelsende im Aufwind
17:58		Gewinne in Zürich: SPI beendet den Handel in der Gewinnzone
17:58		Optimismus in Europa: Euro STOXX 50 schliesst in der Gewinnzone
15:58		Pluszeichen in Zürich: SPI am Nachmittag mit Gewinnen
15:58		Freundlicher Handel in London: FTSE 100 am Nachmittag in der Gewinnzone
15:58		Pluszeichen in Europa: STOXX 50 nachmittags freundlich

17:58

Aufschläge in Europa: Zum Handelsende Gewinne im STOXX 50

17:58

Freundlicher Handel in London: FTSE 100 zum Handelsende im Aufwind

17:58

Gewinne in Zürich: SPI beendet den Handel in der Gewinnzone

17:58

Optimismus in Europa: Euro STOXX 50 schliesst in der Gewinnzone

15:58

Pluszeichen in Zürich: SPI am Nachmittag mit Gewinnen

15:58

Freundlicher Handel in London: FTSE 100 am Nachmittag in der Gewinnzone